1034620-19-3

Basic information

• Product Name: dibenzyl (1-O-hexadecanoyl-2-O-hexadecyl-sn-glycero)phosphite
• Synonyms: dibenzyl (1-O-hexadecanoyl-2-O-hexadecyl-sn-glycero)phosphite
• CAS NO: 1034620-19-3
• Molecular Weight: 799.168
• Mol File: 1034620-19-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: dibenzyl (1-O-hexadecanoyl-2-O-hexadecyl-sn-glycero)phosphite(CAS DataBase Reference)
• NIST Chemistry Reference: dibenzyl (1-O-hexadecanoyl-2-O-hexadecyl-sn-glycero)phosphite(1034620-19-3)
• EPA Substance Registry System: dibenzyl (1-O-hexadecanoyl-2-O-hexadecyl-sn-glycero)phosphite(1034620-19-3)

Safety Data

• Hazardous Substances Data: 1034620-19-3(Hazardous Substances Data)

Upstream product

• 945491-74-7 (S)-2-(hexadecyloxy)-3-hydroxypropyl palmitate 
• 108549-21-9 benzyl-N,N,N',N'-tetraisopropylphosphorodiamidite 

Downstream Products

• 1034620-20-6 3,4,5-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α-D-mannopyranosyl)-1-O-(1-O-hexadecanoyl-2-O-hexadecyl-sn-glycero-3-benzylphosphoryl)-D-myo-inositol 

Relevant articles and documents

ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES

The invention relates to compounds which are immunomodulatory compounds and, in particular, can induce IL-12 secretion. The invention also relates to compositions containing the compounds, precursors, and prodrugs of these compounds, use of these compounds as adjuvants in combination with vaccines, and use of these compounds for treatment of diseases or conditions relating to infection, atopic disorders, or cancer.